304 related articles for article (PubMed ID: 11713615)
1. Behavioural sensitization after repeated exposure to Delta 9-tetrahydrocannabinol and cross-sensitization with morphine.
Cadoni C; Pisanu A; Solinas M; Acquas E; Di Chiara G
Psychopharmacology (Berl); 2001 Nov; 158(3):259-66. PubMed ID: 11713615
[TBL] [Abstract][Full Text] [Related]
2. Behavioral sensitization to delta 9-tetrahydrocannabinol and cross-sensitization with morphine: differential changes in accumbal shell and core dopamine transmission.
Cadoni C; Valentini V; Di Chiara G
J Neurochem; 2008 Aug; 106(4):1586-93. PubMed ID: 18513369
[TBL] [Abstract][Full Text] [Related]
3. Decreased basal endogenous opioid levels in diabetic rodents: effects on morphine and delta-9-tetrahydrocannabinoid-induced antinociception.
Williams J; Haller VL; Stevens DL; Welch SP
Eur J Pharmacol; 2008 Apr; 584(1):78-86. PubMed ID: 18313663
[TBL] [Abstract][Full Text] [Related]
4. Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol.
Cichewicz DL; Welch SP
J Pharmacol Exp Ther; 2003 Jun; 305(3):812-7. PubMed ID: 12606610
[TBL] [Abstract][Full Text] [Related]
5. Synergy between delta9-tetrahydrocannabinol and morphine in the arthritic rat.
Cox ML; Haller VL; Welch SP
Eur J Pharmacol; 2007 Jul; 567(1-2):125-30. PubMed ID: 17498686
[TBL] [Abstract][Full Text] [Related]
6. Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification.
Cichewicz DL; Martin ZL; Smith FL; Welch SP
J Pharmacol Exp Ther; 1999 May; 289(2):859-67. PubMed ID: 10215664
[TBL] [Abstract][Full Text] [Related]
7. Chronic treatment with Delta-9-tetrahydrocannabinol alters the structure of neurons in the nucleus accumbens shell and medial prefrontal cortex of rats.
Kolb B; Gorny G; Limebeer CL; Parker LA
Synapse; 2006 Nov; 60(6):429-36. PubMed ID: 16881072
[TBL] [Abstract][Full Text] [Related]
8. A vapourized Δ(9)-tetrahydrocannabinol (Δ(9)-THC) delivery system part II: comparison of behavioural effects of pulmonary versus parenteral cannabinoid exposure in rodents.
Manwell LA; Ford B; Matthews BA; Heipel H; Mallet PE
J Pharmacol Toxicol Methods; 2014; 70(1):112-9. PubMed ID: 24956154
[TBL] [Abstract][Full Text] [Related]
9. Metabolic mapping of the time-dependent effects of delta 9-tetrahydrocannabinol administration in the rat.
Whitlow CT; Freedland CS; Porrino LJ
Psychopharmacology (Berl); 2002 May; 161(2):129-36. PubMed ID: 11981592
[TBL] [Abstract][Full Text] [Related]
10. Time course of the enhancement and restoration of the analgesic efficacy of codeine and morphine by delta9-tetrahydrocannabinol.
Williams IJ; Edwards S; Rubo A; Haller VL; Stevens DL; Welch SP
Eur J Pharmacol; 2006 Jun; 539(1-2):57-63. PubMed ID: 16687136
[TBL] [Abstract][Full Text] [Related]
11. Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine.
Roberts JD; Gennings C; Shih M
Eur J Pharmacol; 2006 Jan; 530(1-2):54-8. PubMed ID: 16375890
[TBL] [Abstract][Full Text] [Related]
12. THC-methadone and THC-naltrexone interactions on discrimination, antinociception, and locomotion in rats.
Wakley AA; Craft RM
Behav Pharmacol; 2011 Sep; 22(5-6):489-97. PubMed ID: 21716095
[TBL] [Abstract][Full Text] [Related]
13. Repeated exposure to Delta(9)-tetrahydrocannabinol alters heroin-induced locomotor sensitisation and Fos-immunoreactivity.
Singh ME; McGregor IS; Mallet PE
Neuropharmacology; 2005 Dec; 49(8):1189-200. PubMed ID: 16137723
[TBL] [Abstract][Full Text] [Related]
14. Tolerance to the reinforcing effects of morphine in delta9-tetrahydrocannabinol treated mice.
Jardinaud F; Roques BP; Noble F
Behav Brain Res; 2006 Oct; 173(2):255-61. PubMed ID: 16884789
[TBL] [Abstract][Full Text] [Related]
15. Repeated alcohol: behavioral sensitization and alcohol-heightened aggression in mice.
Fish EW; DeBold JF; Miczek KA
Psychopharmacology (Berl); 2002 Feb; 160(1):39-48. PubMed ID: 11862372
[TBL] [Abstract][Full Text] [Related]
16. Morphine-induced behavioral sensitization increased the mRNA expression of NMDA receptor subunits in the rat amygdala.
Sepehrizadeh Z; Sahebgharani M; Ahmadi S; Shapourabadi MB; Bozchlou SH; Zarrindast MR
Pharmacology; 2008; 81(4):333-43. PubMed ID: 18391508
[TBL] [Abstract][Full Text] [Related]
17. Beta-endorphin elevations in the ventral tegmental area regulate the discriminative effects of Delta-9-tetrahydrocannabinol.
Solinas M; Zangen A; Thiriet N; Goldberg SR
Eur J Neurosci; 2004 Jun; 19(12):3183-92. PubMed ID: 15217374
[TBL] [Abstract][Full Text] [Related]
18. Effects of drugs on behavior in pigeons tolerant to delta 9-tetrahydrocannabinol.
McMillan DE; Leander JD; Dudley KH
J Pharmacol Exp Ther; 1980 Jan; 212(1):85-90. PubMed ID: 7351628
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of cannabinol and cannabidiol on THC-induced responses during abstinence in morphine-dependent rats.
Hine B; Torrelio M; Gershon S
Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):185-8. PubMed ID: 1237925
[TBL] [Abstract][Full Text] [Related]
20. Adolescent exposure to chronic delta-9-tetrahydrocannabinol blocks opiate dependence in maternally deprived rats.
Morel LJ; Giros B; Daugé V
Neuropsychopharmacology; 2009 Oct; 34(11):2469-76. PubMed ID: 19553915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]